dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond - summary presentation
Published 3 years ago • 180 plays • Length 8:32Download video MP4
Download video MP3
Similar videos
-
25:32
dr julie lovshin - sglt2i cardiorenal mechanisms in diabetes and beyond
-
34:54
professor stephen wiviott - 'sglt2 outcome trials - an evolving story'
-
19:51
prof nikolaus marx - 'the biology and therapeutic potential of sglt2 inhibition - another year on!'
-
2:36:55
day 2 complete recording
-
28:18
debate a new era in the management of type 2 diabetes & cardiorenal disease
-
38:55
professor milton packer - 'heart failure – are there limits to anti-diabetic therapy with sglt2'
-
46:01
ckd e-learning - sglt-2 inhibitors and ckd - 05.19.21
-
26:50
professor alice cheng - sglt inhibitors - are there no therapeutic limits
-
0:30
sglt2 inhibitors for diabetics
-
22:15
sglt-2 inhibitors for type 2 diabetes - amel arnaout, md
-
30:05
professor david wheeler - renoprotective effects of sglt2 inhibitors
-
9:06
sglt2 inhibitors in chronic kidney disease
-
9:59
dr marc pfeffer - surprising findings from clinical trials – cardiology, diabetes & nephrology
-
59:24
cwmgr: the expanding multiverse of sglti in & beyond diabetes
-
26:36
professor christoph wanner - renoprotective effects of sglt2 inhibitors
-
4:41
cv risk in t2d: role of sglt2 inhibition
-
27:26
understanding type 2 diabetes: linking pathophysiology to therapeutic targets
-
5:41
practical considerations and utility of slgt2 inhibitors in improving cv outcomes